Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
AssigneeNordicCan A/S
InventorSøren Christian Schou
Life of this patent
Estimating the term…
Abstract
A powdered composition is disclosed, the powdered composition comprising a complex between one or more cannabinoids having at least one phenolic moiety and a basic ion exchange resin. Also, an orally dispensable delivery vehicle, a method of manufacturing the powdered composition, a method of manufacturing the orally dispensable delivery vehicle, composition for use as a medicament, composition for use in a treatment, method of treatment, and use of a basic ion exchange resin as a stabilizing agent are disclosed.
Claims21
A cannabinoid chewing gum tablet comprising:
- a gum base portion comprising water-insoluble gum base ingredients, including natural resins in a range of 8 to 45% by weight of the gum base portion;
- a bulk portion comprising bulk sweeteners in an amount of 30 to 70% by weight of the cannabinoid chewing gum tablet;
- and
- a powdered composition comprising a complex between one or more cannabinoids having at least one phenolic moiety and a basic ion exchange resin, wherein said one or more cannabinoids is present in an amount of at least 1 percent by weight of the powdered composition,
- the one or more cannabinoids being present in the cannabinoid chewing gum tablet in an amount of between 1 and 400 milligrams.
A compressed cannabinoid chewing gum tablet comprising:
- gum base granules comprising water-insoluble gum base ingredients, including elastomers in a range of 5 to 40% by weight of the gum base granules;
- a bulk portion comprising bulk sweeteners in an amount of 20 to 80% by weight of the compressed cannabinoid chewing gum tablet;
- and
- a powdered composition comprising a complex between one or more cannabinoids having at least one phenolic moiety and a basic ion exchange resin,
- the one or more cannabinoids being present in the compressed cannabinoid chewing gum tablet in an amount of between 1 and 400 milligrams.
A cannabinoid lozenge tablet comprising:
- a diluent portion present in an amount of 500 to 1100 mg per cannabinoid lozenge tablet;
- one or more excipients selected from the group consisting of taste masking agents, antioxidants, glidants, colorant, and combinations thereof;
- and
- a powdered composition comprising a complex between one or more cannabinoids having at least one phenolic moiety and a basic ion exchange resin,
- the one or more cannabinoids being present in the cannabinoid lozenge tablet in an amount of between 1 and 400 milligrams.
A fast dissolving cannabinoid tablet comprising:
- a soluble excipient present in an amount of 25 to 97.5% by weight of the fast dissolving cannabinoid tablet;
- one or more excipients selected from the group consisting of taste masking agents, antioxidants, glidants, colorant, and combinations thereof;
- and
- a powdered composition comprising a complex between one or more cannabinoids having at least one phenolic moiety and a basic ion exchange resin,
- the one or more cannabinoids being present in the fast dissolving cannabinoid tablet in an amount of between 1 and 400 milligram.
Dependencies are inferred from the claim text.